Afinitor

ESMO: Despite positive trial, Merck's Welireg still comes up short in overall survival
Fierce Pharma
Fri, 09/13/24 - 11:12 am
Merck
Welireg
renal cell carcinoma
Novartis
Afinitor
ESMO
clinical trials
ESMO: Eyeing Novartis and Pfizer, Chi-Med touts neuroendocrine cancer win
Fierce Pharma
Mon, 09/30/19 - 10:38 am
Chi-Med
surufatinib
Pfizer
Sutent
Novartis
Afinitor
Lutathera
neuroendocrine tumors. ESMO
Novartis socked with $1.5M whistleblower verdict
NJ Biz
Tue, 02/26/19 - 06:15 pm
Novartis
whistleblower lawsuits
Afinitor
kickbacks
Novartis cancer drug wins expanded indication in Europe
BioPharma Dive
Sat, 06/4/16 - 06:26 pm
Novartis
Europe
Afinitor
gastrointestinal cancer
Facing rival drugs, Novartis gets win with Afinitor in Europe
Yahoo/Reuters
Thu, 06/2/16 - 10:00 am
Novartis
Europe
Afinitor
cancer
gastrointestinal cancer
Kidney Cancer Drug Boxing Match
Motley Fool
Mon, 10/5/15 - 09:17 am
kidney cancer
Bristol-Myers Squibb
Novartis
Exelixis
Opdivo
Cometriq
Afinitor
Bristol's Opdivo boosts kidney cancer survival beyond two years
Yahoo/Reuters
Sat, 09/26/15 - 09:54 am
Bristol-Myers Squibb
Opdivo
kidney cancer
Novartis
Afinitor
Watch out, Afinitor. Bristol's 'breakthrough' Opdivo is coming for you
Fierce Pharma Marketing
Fri, 09/18/15 - 09:14 pm
Bristol-Myers Squibb
Afinitor
Opdivo
Novartis
kidney cancer
Novartis bullish on Afinitor cancer drug despite new competition
Yahoo/Reuters
Tue, 07/21/15 - 06:52 pm
Novartis
Afinitor
Opdivo
Cometriq
Exelixis
Bristol-Myers Squibb
Novartis granted orphan status for treatment of diffuse large B-cell lymphoma
Yahoo/Fly on the Wall
Wed, 06/4/14 - 09:25 am
orphan drugs
Novartis
diffuse large B-cell lymphoma
Afinitor
FDA
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Novartis discount fails to persuade NICE on Afinitor in breast cancer
Fierce Pharma
Thu, 08/29/13 - 11:08 am
Novartis
NICE
breast cancer
Afinitor
Novartis drug shows no survival benefit in liver cancer
Chicago Tribune, IL
Wed, 08/7/13 - 09:15 am
liver cancer
Novartis
Afinitor
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/6/13 - 09:12 am
kidney cancer
ONYX Pharmaceuticals
Bayer
Nexavar
Roche
Avastin
Inlyta
Sutent
Pfizer
Votrient
GSK
Afinitor
Novartis
BMS-936558
Bristol-Myers Squibb
tivozanib
Aveo Oncology
U.K. Regulators Sour on Novartis Breast Cancer Drug Afinitor
Motley Fool
Sat, 03/23/13 - 09:48 am
Novartis
Afinitor
breast cancer
Novartis says Afinitor reduces tumors in rare genetic disease
Reuters
Fri, 01/11/13 - 11:57 am
Afinitor
Novartis
TSC
Novartis drug Afinitor gets EU nod for breast cancer
Reuters
Mon, 07/30/12 - 10:25 am
Afinitor
Novartis
breast cancer
Europe
Breast Cancer Halted By Novartis Drug From Easter Island
Bloomberg
Mon, 07/23/12 - 08:50 am
Novartis
Afinitor
breast cancer
UPDATE 2-US FDA approves Novartis drug Afinitor for breast cancer
Reuters
Sat, 07/21/12 - 11:51 am
Novartis
Afinitor
breast cancer
Novartis' Afinitor recommended by CHMP for EU approval
Yahoo/Fly on the Wall
Fri, 06/22/12 - 09:29 am
Novartis
Afinitor
Europe
CHMP
breast cancer

Pages